Dexlansoprazole MR for the management of gastroesophageal reflux disease.
about
Pharmacological and Safety Profile of Dexlansoprazole: A New Proton Pump Inhibitor - Implications for Treatment of Gastroesophageal Reflux Disease in the Asia Pacific RegionDexlansoprazole - a new-generation proton pump inhibitorManaging gastroesophageal reflux disease - comparative efficacy and outcomes of dexlansoprazole MR.Gastroesophageal reflux disease and sleep disturbances.First-week clinical responses to dexlansoprazole 60 mg and esomeprazole 40 mg for the treatment of grades A and B gastroesophageal reflux disease.
P2860
Dexlansoprazole MR for the management of gastroesophageal reflux disease.
description
2011 nî lūn-bûn
@nan
2011 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Dexlansoprazole MR for the management of gastroesophageal reflux disease.
@ast
Dexlansoprazole MR for the management of gastroesophageal reflux disease.
@en
type
label
Dexlansoprazole MR for the management of gastroesophageal reflux disease.
@ast
Dexlansoprazole MR for the management of gastroesophageal reflux disease.
@en
prefLabel
Dexlansoprazole MR for the management of gastroesophageal reflux disease.
@ast
Dexlansoprazole MR for the management of gastroesophageal reflux disease.
@en
P2860
P356
P1476
Dexlansoprazole MR for the management of gastroesophageal reflux disease.
@en
P2093
Brian W Behm
David A Peura
P2860
P304
P356
10.1586/EGH.11.37
P577
2011-08-01T00:00:00Z